Millennium Pharmacon International (SDPC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.063x

Based on the latest financial reports, Millennium Pharmacon International (SDPC) has a cash flow conversion efficiency ratio of -0.063x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-18.67 Billion ≈ $-1.09 Million USD) by net assets (Rp296.69 Billion ≈ $17.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Millennium Pharmacon International's balance sheet to measure how much of total assets are equity-financed.

Millennium Pharmacon International - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Millennium Pharmacon International's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Millennium Pharmacon International to evaluate the quality of earnings relative to operating cash generation.

Millennium Pharmacon International Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Millennium Pharmacon International ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
UDAYSHIVAKUMAR INFRA ORD (BSE) NSE:USK	0.029x
BIT MINING C.A SP.ADR 100 F:50C0	N/A
Immo-Zenobe Gramme SA BR:ZEN	N/A
Trustpilot Group PLC LSE:TRST	-5.609x
Good Times Restaurants Inc NASDAQ:GTIM	0.015x
High Peak Royalties Ltd AU:HPR	-0.016x
Skillful Craftsman Education Tech NASDAQ:EDTK	-0.079x
Stuve Gold Corp V:STUV	0.064x

Annual Cash Flow Conversion Efficiency for Millennium Pharmacon International (2004–2024)

The table below shows the annual cash flow conversion efficiency of Millennium Pharmacon International from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see Millennium Pharmacon International (SDPC) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Rp282.50 Billion ≈ $16.55 Million	Rp-125.45 Billion ≈ $-7.35 Million	-0.444x	-34.56%
2023-12-31	Rp277.71 Billion ≈ $16.27 Million	Rp-91.65 Billion ≈ $-5.37 Million	-0.330x	-308.43%
2022-12-31	Rp258.91 Billion ≈ $15.17 Million	Rp41.00 Billion ≈ $2.40 Million	0.158x	+306.44%
2021-12-31	Rp236.98 Billion ≈ $13.89 Million	Rp-18.18 Billion ≈ $-1.07 Million	-0.077x	-124.52%
2020-12-31	Rp229.20 Billion ≈ $13.43 Million	Rp71.69 Billion ≈ $4.20 Million	0.313x	+391.54%
2019-12-31	Rp235.44 Billion ≈ $13.80 Million	Rp-25.26 Billion ≈ $-1.48 Million	-0.107x	-627.27%
2018-12-31	Rp232.11 Billion ≈ $13.60 Million	Rp4.72 Billion ≈ $276.75K	0.020x	-2.94%
2017-12-31	Rp212.61 Billion ≈ $12.46 Million	Rp4.46 Billion ≈ $261.18K	0.021x	+111.13%
2016-12-31	Rp143.28 Billion ≈ $8.40 Million	Rp-26.99 Billion ≈ $-1.58 Million	-0.188x	+63.20%
2015-12-31	Rp134.31 Billion ≈ $7.87 Million	Rp-68.74 Billion ≈ $-4.03 Million	-0.512x	-1218.86%
2014-12-31	Rp121.79 Billion ≈ $7.14 Million	Rp-4.73 Billion ≈ $-276.93K	-0.039x	+91.69%
2013-12-31	Rp114.87 Billion ≈ $6.73 Million	Rp-53.67 Billion ≈ $-3.14 Million	-0.467x	-2326.94%
2012-12-31	Rp104.62 Billion ≈ $6.13 Million	Rp2.19 Billion ≈ $128.61K	0.021x	+118.58%
2011-12-31	Rp94.78 Billion ≈ $5.55 Million	Rp-10.70 Billion ≈ $-626.92K	-0.113x	-273.40%
2007-12-31	Rp70.24 Billion ≈ $4.12 Million	Rp4.57 Billion ≈ $267.94K	0.065x	+391.77%
2006-12-31	Rp60.63 Billion ≈ $3.55 Million	Rp802.62 Million ≈ $47.03K	0.013x	-78.04%
2004-12-31	Rp45.18 Billion ≈ $2.65 Million	Rp2.72 Billion ≈ $159.57K	0.060x	--

About Millennium Pharmacon International

JK:SDPC Indonesia Medical Distribution

Market Cap

$13.74 Million

Rp234.42 Billion IDR

Market Cap Rank

#26222 Global

#579 in Indonesia

Share Price

Rp184.00

Change (1 day)

+1.66%

52-Week Range

Rp128.00 - Rp202.00

All Time High

Rp357.65